| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99c2ef070cdebdcc05bcf4839ede26af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23643cc1c6c54b12be05268df73e5ccd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2001-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83bc324eee36ae70b0a1bb5f4c2a187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9816ab5aebd05998caa616b9d1cba307 |
| publicationDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02076461-A1 |
| titleOfInvention |
Combination of reboxetine and citalopram |
| abstract |
A composition comprising, in combination: a) a pharmaceutically effective amount of reboxetine or a pharmaceutically effective salt thereof; and b) a pharmaceutically effective amount of citalopram or a pharmaceutically effective salt thereof is provided. The composition is useful in treating disorders of diseases of the central nervous system and particularly useful in treating treatment-resistant depression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058353-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007124757-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005079787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007124757-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058353-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010044016-A1 |
| priorityDate |
2001-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |